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Systemic disease due to non-enterococcal group D 
streptococci, particularly Streptococcus bovis, is rare 
in infants and children.le9 There are several reports of 
meningitis due to non-enterococcal group D strepto- 
cocci in infants,1-4,7.8 of which five were due to S. 
bovis.1*2,4,7,8 We describe an additional case of S. bovis 
biotype II meningitis in an infant. This case is unique in 
that the meningitis was associated with eosinophilic 
pleocytosis of the cerebrospinal fluid (CSF). Such an 
association has not been previously reported. 
A 50-day-old female infant was admitted to the 
Northwest Armed Forces Hospital with a history of 
diminished activity, reluctance to feed, and vomiting of 
3 days’ duration. One day prior to admission, she had 
fever. There were no respiratory problems or abnormal 
movements, and there was no diarrhea or skin rash. 
There was no history of recent infections in other family 
members. The baby was born at 33 weeks of gestation, 
with a birth weight of 1835 g. There were no perinatal 
risk factors for infection. At the age of 11 days, the 
baby developed tachypnea, vomiting, and abdominal 
distension. Abdominal X-ray revealed dilated bowel 
loops, but there was no evidence of bowel wall thicken- 
ing, free air, or intramural gas. Septic workup was 
negative. The baby received ampicillin and gentamicin. 
Three days later, the abdominal distension had subsided, 
and enteral feeding was re-established. Antibiotics were 
discontinued after 7 days, and the infant was discharged 
in good condition. She remained well until the present 
illness. 
Physical examination revealed a sick-looking, 
mottled, hypotonic and irritable infant. Her axillary 
temperature was 35.9”C, respiratory rate 35/min, pulse 
rate 160/min, and blood pressure 77/53 mmHg; weight, 
length and head circumference were at the third per- 
centile for age. Neurologic examination did not reveal 
any focal abnormalities. Results of examination of the 
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lungs, heart, abdomen and spine were unremarkable. 
Laboratory studies of blood revealed the following: 
white blood cells (WBCs), 4.09X109/L (neutrophils 
61%) lymphocytes 30%) monocytes 8%) eosinophils 
1%); hemoglobin, 10.7 g/L; and platelets, 522 x 109/L. 
Serum electrolytes, glucose, urea and creatinine were 
within the normal ranges for age. The CSF was turbid. 
CSF analysis showed: WBCs, 1200/mm3 (8% neutrophils, 
2% lymphocytes, 90% eosinophils); glucose, 11 mg/dL; 
and protein, 290 mg/dL. Gram staining of CSF showed 
many Gram-positive diplococci and inflammatory cells. 
Therapy with intravenous ampicillin (200 mglkg per day 
divided into 6-hourly doses) and intravenous cefotaxime 
(300 mg/kg per day divided into 6-hourly doses) was 
started after obtaining blood, CSF and urine for culture. 
Blood, CSF and stool cultures grew an a-hemolytic 
streptococcus identified as S. bovis biotype II by using 
a commercial biochemical identification system (API 
Strep System, bioMerieux, Lyon, France).‘O The organ- 
ism was bile esculin and lactose positive, and failed to 
grow in 6.5% NaCl broth. Biotype II was indicated by its 
inability to utilize mannitol and glycogen. Susceptibility 
testing by the disk diffusion technique using Mueller- 
Hinton Blood Agar (Saudi Prepared Media, Riyadh, 
Saudi Arabia) showed the isolate to be susceptible to 
penicillin, ampicillin, cefotaxime, cefuroxime, and vanco- 
mycin. The minimum inhibitory concentrations (MICs) 
determined with the E-test method (AB Biodisk, Solna, 
Sweden) were as follows: penicillin 0.047 mg/L, ampicillin 
0.047 mg/L, ceftriaxone 0.19 mg/L, cefotaxime 0.19 mg/L, 
gentamicin 1.5 mg/L, and vancomycin 0.25 mg/L. 
On the fourth day of treatment, cefotaxime was 
stopped and ampicillin was continued for 14 days. The 
CSF after 3 and 14 days of treatment was sterile and 
showed decreases in the WBC count and percentage of 
eosinophils to 280/mm3 (71% eosinophils) and 28/mm3 
(0% eosinophils) respectively. Stool microscopy on two 
occasions did not show any ova or parasites. Ultra- 
sonography of the brain done upon admission and at the 
time of discharge was normal. The patient was dis- 
charged in good clinical condition, with no detectable 
neurologic deficit. At the age of 2 years she was thriving 
well, and her physical examination and developmental 
milestones were normal for her age. 
Group D streptococci are subdivided into two 
subgroups: enterococci and non-enterococci. The latter 
group includes S. bovis and S. equinus. S. bovis can be 
a normal isolate from ‘human gastrointestinal and 
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genital tracts, and less frequently from the oral cavity. 
The portal of entry of the organism to the bloodstream 
is presumably via the gastrointestinal tract, due to 
breakdown of the mucosal barrier. In adults, the 
association of S. bovis bacteremia and colonic neoplasm 
is well recognized. l1 Newborn infants may acquire S. 
bovis during delivery from an infected maternal birth 
canal, or as a nosocomial infection. In our patient, the 
gastrointestinal tract was the probable source of sepsis. 
This contention is supported by isolation of S. bovis from 
the stool and the preceding gastrointestinal illness. 
In adults, S. bovis is commonly associated with 
bacteremia and endocarditis, and less frequently with 
meningitis. l1 Invasive disease due to non-enterococci, 
particularly S. bovis, is uncommon in infants and children, 
with most published cases occurring in neonates.lm9 The 
clinical features on presentation are indistinguishable 
from those of sepsis caused by common pathogens 
in this age group. A review of the English-language 
literature revealed nine cases of non-enterococcal 
meningitis1-4,7,8 in infants, five of which were docu- 
mented to be due to S. bovis.1,2,4,7*8 There is a possibility 
that some of the cases of non-enterococcal meningitis 
for which the group was not specified may have also 
been caused by S. bovis. In our patient, the organism was 
seen on Gram stain of the CSF, which is not often the 
case in non-enterococcal meningitis. CSF Gram-stained 
smears were positive in only two of the nine (22%) 
previously reviewed cases of non-enterococcal menin- 
gitis in children for whom CSF Gram-stain results were 
reported.1~~7~s In adults, only one of 13 patients with 
S. bovis meningitis had a positive CSF Gram stain.” 
Our patient differs from previously published 
cases in that there was a predominance of eosinophils in 
the CSE This finding has not been reported before in 
association with non-enterococcal meningitis. Eosinophils 
are not normally present in the CSF. CSF eosinophilic 
pleocytosis has been associated with central nervous 
system infections caused by parasites, such as Angio- 
strongylus cantonensis, Gnathostoma spinigerum, Taenia 
solium, Echinococcus, Paragonimus westermani, 
Schistosoma spp. and Baylisascaris procyonis in areas 
where these infections are endemic.12-l6 Of these para- 
sites, only Echinococcus and Schistosoma are endemic 
in Saudi Arabia, but these infections are precluded in 
this infant, based on her age, clinical manifestations, 
absence of a history of exposure to sources of these 
infections, and recovery without anti-helminthic therapy. 
Other infections causing CSF eosinophilia include 
Coccidioides immitis infection, Cryptococcus neoformans 
infection, myiasis, Rocky Mountain spotted fever, and, 
rarely, viral, treponemal, mycobacterial and bacterial 
infections.15g’6 Noninfectious known causes of significant 
CSF eosinophilic pleocytosis include idiopathic hyper- 
eosinophilic syndrome, seizures, ventriculoperitoneal 
shunt implantation or obstruction, congenital central 
nervous system malformations, administration of 
intraventricular vancomycin or gentamicin, intrathecal 
injection of contrast agents, leukemia or lymphoma with 
central nervous system involvement, rabies vaccination, 
sarcoidosis, cerebral eosinophilic granuloma, and 
nonsteroidal anti-inflam-matory agents.r3,16-*s Our 
patient had none of the previously reported risk factors 
for CSF eosinophilia. CSF eosinophilia in infants is 
extremely rare. It has been described in a few patients 
suffering from fetal and perinatal hypoxia, one patient 
with group B streptococcal meningitis,19 and one patient 
with congenital toxoplasmosis.14 
The lack of concurrent peripheral eosinophilia in 
our patient is not unusual. In most described cases 
of CSF eosinophilia due to bacterial infections, there 
was no peripheral eosinophilia.15J6 Tung et al l7 reported 
CSF eosinophilia in 36 patients with ventriculoperi- 
toneal shunt infections and/or obstructions, and in no 
case was peripheral eosinophilia present. Isolated CSF 
eosinophilia may also occur in parasitic meningitis.12J4 
The absence of concurrent peripheral eosinophilia, as 
well as the absence of clinical manifestations of allergic 
diseases or recurrent bacterial infections in the child or 
family, suggests that the CSF eosinophilia is due neither 
to an allergic response, nor to compensation for an 
abnormality in mobilization of neutrophils.20 
The significance and the pathogenesis of CSF 
eosinophilia in humans are not entirely clear. There is 
concern that eosinophilic meningitis may be associated 
with neurologic damage. Eosinophils produce unique 
toxic inflammatory mediators, and their activation pro- 
duces a wide range of pro-inflammatory cytokines that 
can cause tissue damage and organ dysfunction.13J0,2* 
Two of the eosinophilic granule proteins (eosinophilic 
cationic protein and eosinophil-derived neurotoxin) 
caused cerebrocerebellar dysfunction after injection 
into the CSF or brain of rabbits or guinea pigs.21 It 
is possible that eosinophil-derived granule proteins, 
cytokines, oxidants and other compounds may have a 
potential direct adverse effect on the human nervous 
system. Further studies are needed to address the 
significance of CSF eosinophilia in terms of clinical 
outcome. Although our patient has normal development 
at the age of 2 years, follow-up is needed to identify 
possible mild neurodevelopmental sequelae that may 
become clinically apparent later on. 
This case further supports the importance of S. bovis 
as a cause of sepsis and meningitis in infants. Addi- 
tionally, it illustrates that S. bovis meningitis may be 
added to the list of infections and conditions that are 
associated with eosinophilic pleocytosis of the CSF. 
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